T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$1.71B |
| 2 |
Becton Dickinson
BDX
|
$780M |
| 3 |
Ashland
ASH
|
$727M |
| 4 |
Canadian Natural Resources
CNQ
|
$694M |
| 5 |
Keysight
KEYS
|
$593M |
Top Sells
| 1 |
RTX Corp
RTX
|
$1.83B |
| 2 |
Ecolab
ECL
|
$1.12B |
| 3 |
Crown Castle
CCI
|
$890M |
| 4 |
Phillips 66
PSX
|
$753M |
| 5 |
Gilead Sciences
GILD
|
$689M |
Sector Composition
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.29% |
| 5 | Technology | 9.67% |
